Live Oak Bancshares, Inc. has taken a significant step by registering depositary shares that represent a 1/40th ownership interest in its new Series B Preferred Stock. This registration, filed with the Securities and Exchange Commission on November 12, 2026, is part of the company's strategy to enhance its capital structure and improve liquidity.
The Series B Preferred Stock is designed to offer investors a fixed rate of 8.750% and is non-cumulative. This means that dividends will only be paid when declared by the board, providing the company with flexibility in managing its cash flow. The preferred stock will have a liquidation preference of $1,000 per share, which translates to $25 per depositary share.
Background
Live Oak Bancshares, Inc., incorporated in North Carolina, operates within the state commercial banks sector (SIC 6022). The company is publicly traded on the New York Stock Exchange under the ticker symbols LOB, LOBKV, and LOB-PA. In recent filings, the company has been active, including a Form 8-K filed on the same day as this registration, indicating ongoing corporate activities and developments.
What the Filing Says
The SEC filing outlines the registration of depositary shares for the Series B Preferred Stock, stating, "The securities to be registered hereby are depositary shares...each representing a 1/40th ownership interest in a share of 8.750% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock." This registration aims to facilitate the issuance of these shares on the New York Stock Exchange.
Impact
This development may affect various stakeholders, including investors looking for stable income through dividends and potential institutional investors seeking to diversify their portfolios with preferred shares. Additionally, this move could impact the competitive landscape among state commercial banks as they consider similar strategies to enhance their capital positions.
What's Next
The filing does not specify what happens next, but it is likely that Live Oak Bancshares will proceed with the issuance of the preferred stock and may provide further updates in subsequent filings.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










